Patents by Inventor A. Heather Good

A. Heather Good has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
    Patent number: 6607723
    Abstract: Antibody-mediated xenograft rejection is attenuated by (1) removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's circulation prior to transplantation by extracorporeal perfusion of the recipient's blood over a biocompatible solid support to which the xenoantigens are bound and/or (2) parenterally administering a xenoantibody-inhibiting amount of an identified xenoantigen to the recipient shortly before graft revascularization and thereafter.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 19, 2003
    Assignees: Alberta Research Council, Integris Baptist Medical Center, Inc.
    Inventors: A. Heather Good, David K.C. Cooper, Andrew J. Malcolm
  • Compositions for attenuating antibody- mediated xenograft rejection in human recipients
    Patent number: 5977079
    Abstract: Antibody-mediated xenograft rejection is attenuated by (1) removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's circulation prior to transplantation by extracorporeal perfusion of the recipient's blood over a biocompatible solid support to which the xenoantigens are bound and/or (2) parenterally administering a xenoantibody-inhibiting amount of an identified xenoantigen to the recipient shortly before graft revascularization and thereafter.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: November 2, 1999
    Assignees: Alberta Research Council Edmonton, Integris Baptist Medical Center, Inc.
    Inventors: A. Heather Good, David K.C. Cooper, Andrew J. Malcolm
  • Methods for attenuating antibody-mediated xenograft rejection in human recipients
    Patent number: 5767093
    Abstract: Antibody-mediated xenograft rejection is attenuated by parenterally administering a xenoantibody-inhibiting amount of an identified carbohydrate xenoantigen to the recipient shortly before graft revascularization and thereafter.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 16, 1998
    Assignees: Alberta Research Council, INTEGRIS Baptist Medical Center, Inc.
    Inventors: A. Heather Good, David K. C. Cooper, Andrew J. Malcolm
  • Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
    Patent number: 5695759
    Abstract: Antibody-mediated xenograft rejection is attenuated by (1) removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's circulation prior to transplantation by extracorporeal perfusion of the recipient's blood over a biocompatible solid support to which the xenoantigens are bound and/or (2) parenterally administering a xenoantibody-inhibiting amount of an identified xenoantigen to the recipient shortly before graft revascularization and thereafter.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 9, 1997
    Assignees: Alberta Research Council, Integris Baptist Medical Ctr.
    Inventors: A. Heather Good, David K. C. Cooper, Andrew J. Malcolm
  • Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
    Patent number: 5651968
    Abstract: Antibody-mediated xenograft rejection is attenuated by (1) removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's circulation prior to transplantation by extracorporeal perfusion of the recipient's blood over a biocompatible solid support to which the xenoantigens are bound and/or (2) parenterally administering a xenoantibody-inhibiting amount of an identified xenoantigen to the recipient shortly before graft revascularization and thereafter.
    Type: Grant
    Filed: August 21, 1992
    Date of Patent: July 29, 1997
    Assignee: Alberta Research Council
    Inventors: A. Heather Good, David K. C. Cooper, Andrew J. Malcolm